Test Code LABTXHLATYP (Test Code: 857615) HLA TYPING
Ordering Notes
If Buccal Collection kit is not available in your unit/area, please contact the Transplant Immunology (HLA) Lab at 2-0700.
For STAT turn-around time, please send a request to the Transplant Immunology Laboratory by e-mail at HLA-TIILLab@uchicagomedicine.org and/or by pager #8722.
Specimen and Container/Tube
Specimen Type: whole blood, buccal swab
Preferred Specimen: Lavender top, Flocked Swab (COPAN)
Other Acceptable Specimens: ACD Solution A
Volume
Preferred Volume: Whole blood (EDTA: 4mL, ACD Solution A: 10mL), Buccal swab (4)
Minimum Volume: Whole Blood (4mL), Buccal swab (2)
Specimen Stability
Blood and buccal swab specimens may be kept at room temperature for up to 1 week following collection.
Collection Instructions
Collect specimen per standard laboratory collection procedures.
Specimen Handling and Transport Instructions
UCM Onsite Instructions: Collect specimen per standard collection procedures and send to the laboratory immediately.
UCM Offsite and UC MedLab Outreach Instructions: Collect specimen per standard collection procedures and send to the laboratory using standard transport procedures.
Rejection Criteria
Whole blood specimens will be rejected if collected in incorrect container.
NOTE: For stem cell transplant recipients, the preferred specimen container is buccal swabs. If whole blood is collected and blast% is >5%, the specimen will be rejected and a recollection using buccal swabs will be requested.
Reference Values
No reference range; results may be provided in an interpretive report.
Critical Values
Not Applicable
Turnaround Time
Turnaround times are relative to the time the specimen is received in the testing laboratory section.
STAT Turnaround Time: Low-resolution typing (4 business days); High-resolution typing (Not offered).
Routine Turnaround Time: Low-resolution typing & High-resolution typing (10 business days)
Testing Schedule: M-F 7:00am-7:00pm
Clinical Indications
For translant, HLA typing of patients and potential donors to assess the degree of compatibility between them. The better the match of HLA antigens, the lower the chance for harmful post-transplant immune reactions.
In addition to the indications described above for transplant patients, HLA testing for the following conditions are performed:
Disease association: Patients are HLA typed to determine if they carry genes that are known to be associated with certain diseases. These tests can help physicians diagnose and determine an appropriate treatment plan for their patients.
Drug hypersensitivity: Several drugs are associated with severe reactions if administered to patients that carry certain HLA genes. HLA typing of patients before the prescription of these drugs helps to prevent these potentially life-threatening reactions.
Platelet transfusion support: Patients with low platelet counts are at risk for serious bleeding complications and are often transfused with platelets from healthy donors. However, patients can sometimes produce antibodies to the HLA molecules expressed on platelets, which reduce the effectiveness of platelet transfusion. HLA typing, in addition to antibody detection, help physicians choose a platelet donor that will result in increased platelet counts for patients in need.
Test Components
Low-resolution and High-resolution molecular typing for HLA-A, B, C, DRB1, DRB3/4/5, DQA1, DQB1, DPA1, and/or DPB1.
Level of resolution and HLA-loci tested is determined by purpose of testing. Refer to transplant agreements, where applicable.
CPT Codes
Low Resolution:
HLA Class I and II combined: 81370 + 81376 (x3)
HLA Class I (A, B, C): 81372
Any single HLA Class I: 81373/locus
Any single HLA Class II: 81376/locus
High Resolution:
HLA Class I and Class II: 81378 + 81382 (x5)
HLA Class I (A, B, C): 81379
Any single HLA Class I: 81380/locus
Any single HLA Class II: 81382/locus
Methodology
Low-resolution: Reverse sequence specific oligonucleotide probing (rSSOP)
High-resolution: Next generation sequencing
Synonyms/Key Search Words
HLA Typing, HLA, Typing
Last Review Date
10/16/2024